文献速递免疫规划

全科实践中提高人乳头瘤病毒疫苗接种率的多方面针对性干预:一项实用性整群随机对照试验

A multifaceted, targeted intervention to improve human papillomavirus vaccination rates in general practice: A pragmatic cluster-randomized controlled trial.
PubMed 文献 · Vaccine · 2025-07-04

在瑞士全科医生中开展整群随机对照试验,干预组接受HPV详细信息、宣传单页及HPV推荐话术培训,对照组仅接受一般疫苗接种教育。共56家诊所72名全科医生随机分组,干预对主要结局(研究开始后6个月内每名全科医生接种的首剂HPV疫苗数)无效果(校正率比1.55,95%CI 0.72-3.37),但干预组态度改变的优势比显著更高(校正OR 17.89,95%CI 3.36-95.23),知识增长无组间差异。

要点

  • 多方面针对性干预未增加全科医生接种的首剂HPV疫苗数(校正率比1.55,95%CI 0.72-3.37)。
  • 干预组对HPV疫苗接种态度改变的优势比显著高于对照组(校正OR 17.89,95%CI 3.36-95.23)。
  • 两组知识增长无差异,次要HPV疫苗接种计数结局均未达统计学显著。

核心结论

  • 多方面干预改善了全科医生对HPV疫苗接种的态度,但未能提高HPV疫苗接种率或知识水平。
  • 研究见解可帮助为未来HPV疫苗接种干预的制定提供信息。

研究设计与样本

  • 实用性整群随机对照试验,两组全科医生人数相等,均接受关于一般疫苗接种和国家疫苗接种计划的教育课程。
  • 干预组全科医生额外接受HPV详细信息、宣传单页,并接受HPV推荐话术培训。
  • 共随机分配56家诊所、72名全科医生。

主要发现

  • 全科医生共接种5329剂疫苗,其中含195剂HPV疫苗。
  • 干预对主要结局(研究开始后6个月内每名全科医生接种的首剂HPV疫苗数)无效果:校正率比1.55(95%CI 0.72-3.37)。
  • 次要HPV疫苗接种计数结局(第3个月和第12个月首剂HPV疫苗计数)均未达统计学显著。
  • 干预组态度改变的优势比显著更高:校正OR 17.89(95%CI 3.36-95.23)。
  • 两组知识增长无差异。

关键数值与推荐

  • 主要结局为研究开始后6个月内每名全科医生接种的首剂HPV疫苗数。
  • 次要结局包括第3个月和第12个月的首剂HPV疫苗计数,以及全科医生从基线到第6个月对HPV疫苗接种态度和知识的变化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human papillomavirus (HPV) vaccination rates are low in Switzerland. The aim of the study was to test a pragmatic multifaceted targeted intervention among general practitioners (GPs) to increase HPV vaccination (HPVv) rates in general practice. METHODS: In this cluster-randomized controlled trial, two equally sized groups of GPs each received an educational session on vaccination in general and on the national vaccination schedule. Treatment group GPs additionally received detailed information about HPV, information leaflets, and were instructed on HPV announcement training as an approach to recommend HPVv. Primary outcome was the number of first HPVv doses administered per GP up to six months after study start (T6). Secondary outcomes were first HPVv dose counts at T3 and T12 and the GPs' changes in attitudes and knowledge regarding HPVv from baseline to T6. Outcomes were analysed using mixed-effects Poisson and logistic regression models. RESULTS: A total of N = 56 practices with n = 72 GPs were randomized. GPs administered a total of 5329 vaccine doses including 195 HPVv doses. The intervention had no effect on the primary outcome (adjusted rate ratio [95 % CI]: 1.55 [0.72-3.37]), and none of the secondary HPVv count outcomes reached statistical significance. The treatment group showed significantly higher odds of changing attitudes towards HPVv (adjusted odds ratio [95 % CI]: 17.89 [3.36-95.23]). We found no difference in knowledge gain between the groups. CONCLUSION: The multifaceted intervention improved attitudes towards HPVv but failed to increase HPVv rates or knowledge. Insights from the study can help inform the development of future HPVv interventions. TRIAL REGISTRATION: ISRCTN 55473884, first registered on 04/06/2021.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Plate A, Jäger L, Di Gangi S, et al. A multifaceted, targeted intervention to improve human papillomavirus vaccination rates in general practice: A pragmatic cluster-randomized controlled trial. Vaccine. 2025. PMID: 40617087. doi:10.1016/j.vaccine.2025.127444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。